Sars-cov-2 mrna-1273 (6m-5y) vaccine Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with sars-cov-2 mrna-1273 (6m-5y) vaccine
D
- dacarbazine
- daclizumab
- Dacogen (decitabine)
- dactinomycin
- Dalalone (dexamethasone)
- Dalalone DP (dexamethasone)
- Dalalone LA (dexamethasone)
- Danyelza (naxitamab)
- Daptacel (DTaP) (diphtheria and tetanus toxoids / pertussis, acellular)
- daratumumab
- daratumumab / hyaluronidase
- Darzalex (daratumumab)
- Darzalex Faspro (daratumumab / hyaluronidase)
- dasatinib
- daunorubicin
- daunorubicin liposomal
- DaunoXome (daunorubicin liposomal)
- De-Sone LA (dexamethasone)
- Decadron (dexamethasone)
- Decadron Phosphate, Injectable (dexamethasone)
- Decadron with Xylocaine (dexamethasone / lidocaine)
- Decadron-LA (dexamethasone)
- Decaject (dexamethasone)
- Decaject LA (dexamethasone)
- Decavac (Td) (diphtheria toxoid/tetanus toxoid)
- decitabine
- deflazacort
- Delta-Cortef (prednisolone)
- Deltasone (prednisone)
- dengue vaccine
- Dengvaxia (dengue vaccine)
- denileukin diftitox
- Denzapine (clozapine)
- Dep Medalone 80 (methylprednisolone)
- Depmedalone (methylprednisolone)
- Depo-Medrol (methylprednisolone)
- Depoject-80 (methylprednisolone)
- Depopred (methylprednisolone)
- deucravacitinib
- Dexabliss (dexamethasone)
- Dexacen-4 (dexamethasone)
- Dexacort Phosphate in Respihaler (dexamethasone)
- Dexacort-LA (dexamethasone)
- Dexacorten (dexamethasone)
- dexamethasone
- Dexamethasone Intensol (dexamethasone)
- dexamethasone / ketorolac / moxifloxacin
- dexamethasone / lidocaine
- dexamethasone / moxifloxacin
- Dexasone (dexamethasone)
- Dexasone LA (dexamethasone)
- Dexone (dexamethasone)
- Dexone LA (dexamethasone)
- Dexpak Taperpak (dexamethasone)
- dimethyl fumarate
- dinutuximab
- Diphtheria and Tetanus Toxoids Adsorbed (for Pediatric Use) (DT) (diphtheria toxoid/tetanus toxoid)
- diphtheria and tetanus toxoids / pertussis, acellular
- diphtheria toxoid / haemophilus b conjugate (hboc) vaccine / pertussis, whole cell / tetanus toxoid
- diphtheria toxoid / haemophilus b conjugate (prp-omp) vaccine / hepatitis b pediatric vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid
- diphtheria toxoid / haemophilus b conjugate (prp-t) vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid
- diphtheria toxoid / haemophilus b conjugate (prp-t) vaccine / pertussis, acellular / tetanus toxoid
- diphtheria toxoid / hepatitis b pediatric vaccine / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid
- diphtheria toxoid / pertussis, acellular / poliovirus vaccine, inactivated / tetanus toxoid
- diphtheria toxoid / pertussis, acellular / tetanus toxoid
- diphtheria toxoid / pertussis, whole cell / tetanus toxoid
- diphtheria toxoid/tetanus toxoid
- diroximel fumarate
- Docefrez (docetaxel)
- docetaxel
- Docivyx (docetaxel)
- Doxil (doxorubicin liposomal)
- doxorubicin
- doxorubicin liposomal
- Droxia (hydroxyurea)
- Dryvax (smallpox vaccine)
- DTIC-Dome (dacarbazine)
- Duralone (methylprednisolone)
- durvalumab
- duvelisib
- Dxevo (dexamethasone)
More about sars-cov-2 mrna-1273 (6m-5y) vaccine
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.